The vaccine is recommended for the following persons 2 years of age and older: • Travelers to areas with increased rates of hepatitis A • Men who have sex with men • Injecting and non-injecting drug users • Persons with clotting-factor disorders (e.g. hemophilia) • Persons with chronic liver disease • Children living in areas with increased rates of hepatitis A during the baseline period from 1987-1997